- Home
- CATX vs BLDE Comparison
CATX vs BLDE Comparison
Compare CATX & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- BLDE
- Stock Information
- Founded
- CATX 1983
- BLDE 2014
- Country
- CATX United States
- BLDE United States
- Employees
- CATX N/A
- BLDE N/A
- Industry
- CATX Medical/Dental Instruments
- BLDE Aerospace
- Sector
- CATX Health Care
- BLDE Consumer Discretionary
- Exchange
- CATX Nasdaq
- BLDE Nasdaq
- Market Cap
- CATX 239.0M
- BLDE 285.2M
- IPO Year
- CATX N/A
- BLDE N/A
- Fundamental
- Price
- CATX $3.97
- BLDE $4.15
- Analyst Decision
- CATX Strong Buy
- BLDE Strong Buy
- Analyst Count
- CATX 11
- BLDE 2
- Target Price
- CATX $12.90
- BLDE $6.25
- AVG Volume (30 Days)
- CATX 1.3M
- BLDE 682.5K
- Earning Date
- CATX 08-11-2025
- BLDE 08-06-2025
- Dividend Yield
- CATX N/A
- BLDE N/A
- EPS Growth
- CATX N/A
- BLDE N/A
- EPS
- CATX N/A
- BLDE N/A
- Revenue
- CATX $1,471,000.00
- BLDE $251,485,000.00
- Revenue This Year
- CATX N/A
- BLDE $5.58
- Revenue Next Year
- CATX N/A
- BLDE $8.56
- P/E Ratio
- CATX N/A
- BLDE N/A
- Revenue Growth
- CATX N/A
- BLDE 8.67
- 52 Week Low
- CATX $1.60
- BLDE $2.35
- 52 Week High
- CATX $16.55
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- CATX 61.19
- BLDE 60.45
- Support Level
- CATX $3.33
- BLDE $4.12
- Resistance Level
- CATX $3.69
- BLDE $4.32
- Average True Range (ATR)
- CATX 0.38
- BLDE 0.20
- MACD
- CATX 0.01
- BLDE -0.00
- Stochastic Oscillator
- CATX 64.23
- BLDE 80.00
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.